Neurology Billing That Understands Your Brain (And Your Business)
Between complex EEG interpretations and ever-changing migraine injection guidelines, neurology billing requires specialized knowledge. We speak fluent "neuro" - whether it's distinguishing between 95907 and 95908 for nerve conduction studies or properly documenting medical necessity for Botox therapy.
Last quarter, we helped a 5-physician neurology group recover $143,000 in previously denied claims for EMG/NCS studies alone. But what our partners value most isn't just the revenue - it's getting back hours previously spent arguing with payers about why an epilepsy monitoring session shouldn't be bundled with a routine consult.
Coding That Navigates Neurology's Gray Matter
We know the difference matters when coding:
- 95907 vs 95908 - Nerve conduction studies with/without F-waves
- 64612 vs 64615 - Chemodenervation for migraines vs spasticity
- EEG add-ons - Proper use of 95955, 95956, and 95957
Real Example: For a patient receiving Botox for chronic migraines, we ensure documentation includes:
✓ Headache frequency/duration ✓ Previous treatments tried ✓ Specific muscles injected ✓ Units administered per site
Prior Auths That Don't Give You a Headache
We've streamlined approvals for:
Diagnostics
- Sleep studies (95810, 95811)
- Neuropsychological testing
Therapies
- IVIG for CIDP
- Sphenopalatine ganglion blocks
Pro Tip: We maintain a database of payer-specific requirements - like which insurers require failed oral preventives before approving migraine biologics.
Fighting Denials Like We're Defending a Thesis
Common neurology denials we routinely overturn:
Our Appeal Success Includes:
✓ 92% overturn rate for medically necessary vagus nerve stimulator adjustments
✓ $68K recovered in one month for a MS practice's denied infusion claims
✓ 100% resolution rate for "experimental" denials on FDA-approved neurostimulators
Business Intelligence That Actually Makes Sense
Our neurology-specific dashboards track what matters:
RVUs
By provider & procedure
Denial %
By payer & CPT
Days to Pay
By test type
Cost/Collect
For infusion therapies
One practice used our data to renegotiate their EMG reimbursement rates - resulting in a 17% increase per study.
"As a cognitive neurologist, I was drowning in prior auth requests for amyloid PET scans. Their team not only streamlined our approval process but caught that we were undercoding our dementia workups. In six months, they increased our collections by 31% - without us seeing more patients."
Dr. Michael Rostov
Behavioral Neurology Associates